Skip to main content

Table 1 Baseline and CMR Characteristics of Patients with and without Myocardial Ischemia (N = 1342)

From: Prognostic value of stress cardiovascular magnetic resonance in asymptomatic patients with known coronary artery disease

 

All patients

(N = 1342)

No ischemia

(N = 966)

Ischemia

(N = 376)

p value

Age (years)

67.7 ± 10.5

67.2 ± 10.7

69.0 ± 9.3

0.003

Males, n (%)

1101 (82.0)

781 (80.8)

320 (85.1)

0.024

Body mass index (kg/m2)

27.2 ± 4.0

27.1 ± 3.9

27.5 ± 4.0

0.135

Coronary risk factors, n (%)

    

 Diabetes mellitus

409 (30.5)

258 (26.7)

151 (40.2)

 < 0.001

 Hypertension

691 (51.5)

468 (48.4)

223 (59.3)

 < 0.001

 Dyslipidemia

849 (63.3)

589 (61.0)

260 (69.1)

0.006

 Current or previous smoking

324 (24.1)

244 (25.3)

80 (21.3)

0.144

 Family history of CAD

431 (32.1)

309 (32.0)

122 (32.4)

0.923

 Obesitya

310 (23.1)

220 (22.8)

90 (23.9)

0.703

Medical history of CV disease, n (%)

    

 Prior PCI

735 (54.8)

552 (57.1)

183 (48.7)

0.006

 Prior CABG

431 (32.1)

309 (32.0)

122 (32.4)

0.923

 Prior MI

746 (55.6)

570 (59.0)

176 (46.8)

 < 0.001

 Peripheral atheroma

115 (8.6)

64 (6.6)

51 (13.6)

 < 0.001

 Ischemic stroke

35 (2.6)

28 (2.9)

7 (1.9)

0.379

 Pacemaker

2 (0.1)

1 (0.1)

1 (0.3)

0.482

 Renal failureb

16 (1.2)

12 (1.2)

4 (1.1)

1.000

 Heart failure hospitalization

31 (2.3)

24 (2.5)

7 (1.9)

0.631

Indications to stress CMR (multiple possible), n (%)

    

 PCI or CABG follow-upc

1184 (88.2)

830 (85.9)

354 (94.1)

 < 0.001

 Inconclusive stress test

107 (8.0)

65 (6.7)

42 (11.2)

0.01

 Inconclusive CCTAd

110 (8.2)

60 (6.2)

50 (13.3)

 < 0.001

Cardiac rhythm, n (%)

    

 Sinus rhythm

1151 (85.8)

818 (84.7)

333 (88.6)

 

 Sinus rhythm with extrasystoles

185 (13.8)

145 (15.0)

40 (10.6)

0.039

 Atrial fibrillation/supraventricular arrhythmias

6 (0.4)

3 (0.3)

3 (0.8)

 

LV ejection fraction, %

45.8 ± 12.5

45.1 ± 12.5

47.7 ± 12.5

< 0.001

LV end-diastolic volume index, ml/m2

100.2 ± 31.3

102.2 ± 32.1

95.1 ± 28.4

 < 0.001

LV end-systolic volume index, ml/m2

57.1 ± 27.4

58.9 ± 27.7

52.2 ± 25.8

 < 0.001

LV mass, g/m2

73.8 ± 7.1

73.6 ± 7.2

73.5 ± 7.1

0.319

RV ejection fraction, %

57.2 ± 11.2

57.1 ± 11.3

57.3 ± 12.9

0.429

Presence of LGE, n (%)

689 (51.3)

502 (52.0)

187 (49.7)

0.018

Presence of viabilitye, n (%)

280 (20.9)

175 (18.1)

105 (27.9)

 < 0.001

 Number of segments of LGE

2.3 ± 1.9

2.4 ± 1.9

2.2 ± 2.0

0.268

 Number of segments of myocardial ischemia

0.7 ± 1.5

0.0 ± 0.0

2.5 ± 1.7

 < 0.001

HR at baseline, beats/min

67 ± 12

67 ± 12

71 ± 13

0.512

HR at stress, beats/min

91 ± 9

90 ± 9

96 ± 11

0.069

RPP at baseline (k), mmHg-beats/min

9.1 (7.5–10.6)

9.0 (7.5–10.6)

9.2 (7.5–11.0)

0.621

RPP at stress (k), mmHg-beats/min

10.6 (9.0–12.4)

10.4 (9.0–12.4)

10.9 (9.5–12.8)

0.193

  1. Values are n (%), mean ± SD, or median (interquartile range)
  2. BMI body mass index, CABG coronary artery bypass grafting, CAD coronary artery disease, CCTA coronary computed tomography angiography, CMR cardiovascular magnetic resonance, CV cardiovascular disease, GFR glomerular filtration rate, HF heart failure, HR heart rate, LGE late gadolinium enhancement, LV left ventricle, MI myocardial infarction, PCI percutaneous coronary intervention, RPP rate-pressure product (pressure mmHg x Heart rate bpm)/1000, RV right ventricle, SD standard deviation
  3. aBMI ≥ 30 kg/m2
  4. bGlomerular filtration rate < 60 ml/min/1.73 m2
  5. cTo detect myocardial ischemia in asymptomatic patient every 3 to 5 years in accordance with ESC guidelines. (REF)
  6. dCoronary stenosis of unknown significance on CCTA
  7. ePresence of LGE with < 50% transmurality